EP Wealth Advisors’s Tenaya Therapeutics TNYA Stock Holding History

EP Wealth Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,224	Closed	-$21.7K	–	1323
2024 Q3	$21.7K	Buy	+11,224	New	+$31.7K	﹤0.01%	1172

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

EP Wealth Advisors's TNYA Position: Q4 2024 in Review

EP Wealth Advisors sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 11,224 shares — an estimated $21.7K sold.

EP Wealth Advisors first reported a position in TNYA in Q3 2024 and held it in 1 quarter. The position peaked at $21.7K in Q3 2024. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

EP Wealth Advisors reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
EP Wealth Advisors sold 11,224 Tenaya Therapeutics shares in Q4 2024, an estimated $21.7K.
EP Wealth Advisors first reported a position in Tenaya Therapeutics in Q3 2024 and held it in 1 quarter.
EP Wealth Advisors's Tenaya Therapeutics position peaked at $21.7K in Q3 2024.
88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on EP Wealth Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.